nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—PPP3CA—pons—autistic disorder	0.057	0.129	CbGeAlD
Tacrolimus—PPP3CA—telencephalic ventricle—autistic disorder	0.0469	0.106	CbGeAlD
Tacrolimus—Sirolimus—EIF4E—autistic disorder	0.0341	1	CrCbGaD
Tacrolimus—PPP3CA—hindbrain—autistic disorder	0.0221	0.0501	CbGeAlD
Tacrolimus—ABCA5—eye—autistic disorder	0.0183	0.0414	CbGeAlD
Tacrolimus—ABCA5—telencephalon—autistic disorder	0.0167	0.0377	CbGeAlD
Tacrolimus—MTOR—hindbrain—autistic disorder	0.0164	0.037	CbGeAlD
Tacrolimus—PPP3CA—brainstem—autistic disorder	0.0127	0.0287	CbGeAlD
Tacrolimus—PPP3CA—forebrain—autistic disorder	0.0122	0.0277	CbGeAlD
Tacrolimus—PPP3CA—telencephalon—autistic disorder	0.0113	0.0255	CbGeAlD
Tacrolimus—ABCA5—head—autistic disorder	0.0104	0.0235	CbGeAlD
Tacrolimus—ABCA5—nervous system—autistic disorder	0.00984	0.0223	CbGeAlD
Tacrolimus—ABCA5—central nervous system—autistic disorder	0.00947	0.0214	CbGeAlD
Tacrolimus—MTOR—brainstem—autistic disorder	0.00937	0.0212	CbGeAlD
Tacrolimus—ABCA5—cerebellum—autistic disorder	0.00926	0.021	CbGeAlD
Tacrolimus—MTOR—eye—autistic disorder	0.00912	0.0206	CbGeAlD
Tacrolimus—MTOR—forebrain—autistic disorder	0.00904	0.0205	CbGeAlD
Tacrolimus—PPP3CA—digestive system—autistic disorder	0.00859	0.0195	CbGeAlD
Tacrolimus—MTOR—telencephalon—autistic disorder	0.00832	0.0188	CbGeAlD
Tacrolimus—FKBP1A—eye—autistic disorder	0.00821	0.0186	CbGeAlD
Tacrolimus—FKBP1A—forebrain—autistic disorder	0.00813	0.0184	CbGeAlD
Tacrolimus—ABCA5—brain—autistic disorder	0.00752	0.017	CbGeAlD
Tacrolimus—FKBP1A—telencephalon—autistic disorder	0.00748	0.0169	CbGeAlD
Tacrolimus—PPP3CA—head—autistic disorder	0.00701	0.0159	CbGeAlD
Tacrolimus—PPP3CA—nervous system—autistic disorder	0.00665	0.015	CbGeAlD
Tacrolimus—PPP3CA—central nervous system—autistic disorder	0.0064	0.0145	CbGeAlD
Tacrolimus—MTOR—digestive system—autistic disorder	0.00635	0.0144	CbGeAlD
Tacrolimus—PPP3CA—cerebellum—autistic disorder	0.00625	0.0142	CbGeAlD
Tacrolimus—FKBP1A—digestive system—autistic disorder	0.00571	0.0129	CbGeAlD
Tacrolimus—MTOR—head—autistic disorder	0.00518	0.0117	CbGeAlD
Tacrolimus—PPP3CA—brain—autistic disorder	0.00508	0.0115	CbGeAlD
Tacrolimus—MTOR—nervous system—autistic disorder	0.00491	0.0111	CbGeAlD
Tacrolimus—MTOR—central nervous system—autistic disorder	0.00473	0.0107	CbGeAlD
Tacrolimus—FKBP1A—head—autistic disorder	0.00466	0.0105	CbGeAlD
Tacrolimus—MTOR—cerebellum—autistic disorder	0.00462	0.0105	CbGeAlD
Tacrolimus—FKBP1A—nervous system—autistic disorder	0.00442	0.01	CbGeAlD
Tacrolimus—FKBP1A—central nervous system—autistic disorder	0.00425	0.00962	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—autistic disorder	0.00416	0.00941	CbGeAlD
Tacrolimus—MTOR—brain—autistic disorder	0.00375	0.00849	CbGeAlD
Tacrolimus—ORM1—nervous system—autistic disorder	0.00346	0.00783	CbGeAlD
Tacrolimus—FKBP1A—brain—autistic disorder	0.00338	0.00764	CbGeAlD
Tacrolimus—ORM1—central nervous system—autistic disorder	0.00333	0.00753	CbGeAlD
Tacrolimus—CYP3A5—digestive system—autistic disorder	0.00249	0.00563	CbGeAlD
Tacrolimus—ALB—brain—autistic disorder	0.00232	0.00525	CbGeAlD
Tacrolimus—ABCB1—forebrain—autistic disorder	0.00188	0.00426	CbGeAlD
Tacrolimus—CYP3A4—digestive system—autistic disorder	0.00187	0.00422	CbGeAlD
Tacrolimus—ABCB1—telencephalon—autistic disorder	0.00173	0.00392	CbGeAlD
Tacrolimus—CYP3A4—nervous system—autistic disorder	0.00144	0.00327	CbGeAlD
Tacrolimus—CYP3A4—central nervous system—autistic disorder	0.00139	0.00314	CbGeAlD
Tacrolimus—ABCB1—digestive system—autistic disorder	0.00132	0.00299	CbGeAlD
Tacrolimus—ABCB1—head—autistic disorder	0.00108	0.00244	CbGeAlD
Tacrolimus—ABCB1—nervous system—autistic disorder	0.00102	0.00231	CbGeAlD
Tacrolimus—ABCB1—central nervous system—autistic disorder	0.000983	0.00223	CbGeAlD
Tacrolimus—ABCB1—cerebellum—autistic disorder	0.000961	0.00218	CbGeAlD
Tacrolimus—ABCB1—brain—autistic disorder	0.000781	0.00177	CbGeAlD
Tacrolimus—CYP3A4—Metabolism—BTD—autistic disorder	8.39e-05	0.00016	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF2—autistic disorder	8.32e-05	0.000159	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—autistic disorder	8.27e-05	0.000158	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC25A12—autistic disorder	8.25e-05	0.000157	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ADSL—autistic disorder	8.16e-05	0.000156	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MEF2C—autistic disorder	8.16e-05	0.000156	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TSC2—autistic disorder	8.11e-05	0.000155	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—HRAS—autistic disorder	8.1e-05	0.000155	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SERPINE1—autistic disorder	8.03e-05	0.000153	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC19A1—autistic disorder	8.02e-05	0.000153	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—XDH—autistic disorder	8e-05	0.000153	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—autistic disorder	7.97e-05	0.000152	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LEP—autistic disorder	7.93e-05	0.000151	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOE—autistic disorder	7.93e-05	0.000151	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLA2G4A—autistic disorder	7.86e-05	0.00015	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—STX1A—autistic disorder	7.86e-05	0.00015	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NPAS2—autistic disorder	7.86e-05	0.00015	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD1—autistic disorder	7.82e-05	0.000149	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TSC1—autistic disorder	7.82e-05	0.000149	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTGS2—autistic disorder	7.76e-05	0.000148	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—autistic disorder	7.75e-05	0.000148	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—MAPK1—autistic disorder	7.69e-05	0.000147	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DHFR—autistic disorder	7.68e-05	0.000147	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—RORA—autistic disorder	7.66e-05	0.000146	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NTRK2—autistic disorder	7.61e-05	0.000145	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TCN2—autistic disorder	7.59e-05	0.000145	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD3—autistic disorder	7.58e-05	0.000145	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PRKCB—autistic disorder	7.48e-05	0.000143	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—ITGB3—autistic disorder	7.45e-05	0.000142	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL5—autistic disorder	7.42e-05	0.000141	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-A—autistic disorder	7.39e-05	0.000141	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	7.38e-05	0.000141	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CALCA—autistic disorder	7.32e-05	0.00014	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ADA—autistic disorder	7.24e-05	0.000138	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—AVP—autistic disorder	7.23e-05	0.000138	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MAOB—autistic disorder	7.18e-05	0.000137	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APC—autistic disorder	7.16e-05	0.000137	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PIK3CG—autistic disorder	7.16e-05	0.000137	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	7.15e-05	0.000136	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ADSL—autistic disorder	7.15e-05	0.000136	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TDO2—autistic disorder	7.13e-05	0.000136	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—POMC—autistic disorder	7.11e-05	0.000136	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—MAPK1—autistic disorder	7.1e-05	0.000135	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PTEN—autistic disorder	7.08e-05	0.000135	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EGF—autistic disorder	7.08e-05	0.000135	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TSC2—autistic disorder	7.05e-05	0.000135	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—XDH—autistic disorder	7.01e-05	0.000134	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—STX1A—autistic disorder	6.88e-05	0.000131	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NPAS2—autistic disorder	6.88e-05	0.000131	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	6.85e-05	0.000131	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—autistic disorder	6.84e-05	0.000131	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HLA-A—autistic disorder	6.82e-05	0.00013	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—POMC—autistic disorder	6.81e-05	0.00013	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PTEN—autistic disorder	6.8e-05	0.00013	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTEN—autistic disorder	6.77e-05	0.000129	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—HRAS—autistic disorder	6.75e-05	0.000129	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DRB1—autistic disorder	6.75e-05	0.000129	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DHCR7—autistic disorder	6.7e-05	0.000128	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TPH2—autistic disorder	6.68e-05	0.000127	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TCN2—autistic disorder	6.65e-05	0.000127	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—RORA—autistic disorder	6.6e-05	0.000126	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DPYD—autistic disorder	6.57e-05	0.000125	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF1—autistic disorder	6.55e-05	0.000125	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TSC2—autistic disorder	6.51e-05	0.000124	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PRKCB—autistic disorder	6.51e-05	0.000124	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—autistic disorder	6.5e-05	0.000124	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRL—autistic disorder	6.47e-05	0.000123	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—autistic disorder	6.46e-05	0.000123	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOE—autistic disorder	6.37e-05	0.000122	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—EXT1—autistic disorder	6.36e-05	0.000121	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC6A8—autistic disorder	6.36e-05	0.000121	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ADA—autistic disorder	6.34e-05	0.000121	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	6.34e-05	0.000121	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SERPINE1—autistic disorder	6.22e-05	0.000119	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MAOB—autistic disorder	6.18e-05	0.000118	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HRAS—autistic disorder	6.17e-05	0.000118	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EGF—autistic disorder	6.16e-05	0.000117	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRB2—autistic disorder	6.14e-05	0.000117	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTEN—autistic disorder	6.11e-05	0.000117	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CACNA1C—autistic disorder	6.11e-05	0.000116	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PRKCB—autistic disorder	6.1e-05	0.000116	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	6.09e-05	0.000116	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DAO—autistic disorder	6.06e-05	0.000116	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—autistic disorder	6.02e-05	0.000115	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP19A1—autistic disorder	6.02e-05	0.000115	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	6e-05	0.000114	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—autistic disorder	5.94e-05	0.000113	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—autistic disorder	5.91e-05	0.000113	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.89e-05	0.000112	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PIK3CG—autistic disorder	5.83e-05	0.000111	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—UPB1—autistic disorder	5.81e-05	0.000111	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—RORA—autistic disorder	5.78e-05	0.00011	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—EGF—autistic disorder	5.77e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AVP—autistic disorder	5.77e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MAPK1—autistic disorder	5.75e-05	0.00011	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TPH2—autistic disorder	5.75e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APC—autistic disorder	5.75e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF2—autistic disorder	5.74e-05	0.00011	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HRAS—autistic disorder	5.7e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EGF—autistic disorder	5.68e-05	0.000108	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DPYD—autistic disorder	5.66e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—COMT—autistic disorder	5.6e-05	0.000107	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTP1—autistic disorder	5.57e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MAOA—autistic disorder	5.56e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DHFR—autistic disorder	5.55e-05	0.000106	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MAPK1—autistic disorder	5.5e-05	0.000105	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—autistic disorder	5.45e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PLA2G4A—autistic disorder	5.42e-05	0.000103	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CAT—autistic disorder	5.42e-05	0.000103	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MAOB—autistic disorder	5.42e-05	0.000103	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ASMT—autistic disorder	5.4e-05	0.000103	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM5—autistic disorder	5.4e-05	0.000103	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF1—autistic disorder	5.34e-05	0.000102	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	5.31e-05	0.000101	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MEF2C—autistic disorder	5.27e-05	0.000101	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CACNA1C—autistic disorder	5.26e-05	0.0001	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ITGB3—autistic disorder	5.14e-05	9.81e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PLA2G4A—autistic disorder	5.12e-05	9.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTM1—autistic disorder	5.12e-05	9.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC25A12—autistic disorder	5.08e-05	9.69e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SERPINE1—autistic disorder	5.07e-05	9.68e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—POMC—autistic disorder	5.06e-05	9.65e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TPH2—autistic disorder	5.04e-05	9.61e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—autistic disorder	5.04e-05	9.61e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SERPINE1—autistic disorder	5e-05	9.54e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—BCL2—autistic disorder	4.98e-05	9.5e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MAPK1—autistic disorder	4.97e-05	9.48e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DPYD—autistic disorder	4.96e-05	9.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC19A1—autistic disorder	4.94e-05	9.43e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—autistic disorder	4.93e-05	9.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GPX1—autistic disorder	4.9e-05	9.35e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2A—autistic disorder	4.8e-05	9.16e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DHFR—autistic disorder	4.78e-05	9.13e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTEN—autistic disorder	4.74e-05	9.04e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—HRAS—autistic disorder	4.62e-05	8.82e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CACNA1C—autistic disorder	4.61e-05	8.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TSC2—autistic disorder	4.56e-05	8.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—autistic disorder	4.52e-05	8.63e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—autistic disorder	4.46e-05	8.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LEP—autistic disorder	4.46e-05	8.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HRAS—autistic disorder	4.44e-05	8.46e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—autistic disorder	4.42e-05	8.44e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HRAS—autistic disorder	4.42e-05	8.43e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADSL—autistic disorder	4.41e-05	8.4e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—autistic disorder	4.38e-05	8.36e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—autistic disorder	4.36e-05	8.33e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP19A1—autistic disorder	4.35e-05	8.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—XDH—autistic disorder	4.32e-05	8.24e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—STX1A—autistic disorder	4.24e-05	8.09e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NPAS2—autistic disorder	4.24e-05	8.09e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—autistic disorder	4.23e-05	8.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—autistic disorder	4.21e-05	8.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRKCB—autistic disorder	4.21e-05	8.03e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DHFR—autistic disorder	4.19e-05	8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PTEN—autistic disorder	4.12e-05	7.87e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—autistic disorder	4.11e-05	7.83e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TCN2—autistic disorder	4.1e-05	7.81e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—COMT—autistic disorder	4.04e-05	7.72e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	4.03e-05	7.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CG—autistic disorder	4.03e-05	7.68e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APC—autistic disorder	4.03e-05	7.68e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTP1—autistic disorder	4.03e-05	7.68e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MAOA—autistic disorder	4.02e-05	7.66e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HRAS—autistic disorder	3.99e-05	7.61e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EGF—autistic disorder	3.98e-05	7.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAT—autistic disorder	3.92e-05	7.47e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADA—autistic disorder	3.91e-05	7.45e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK1—autistic disorder	3.85e-05	7.35e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—autistic disorder	3.83e-05	7.31e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—autistic disorder	3.82e-05	7.29e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTEN—autistic disorder	3.81e-05	7.26e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CG—autistic disorder	3.8e-05	7.25e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP19A1—autistic disorder	3.75e-05	7.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PLA2G4A—autistic disorder	3.7e-05	7.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTM1—autistic disorder	3.7e-05	7.06e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—autistic disorder	3.69e-05	7.03e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—autistic disorder	3.62e-05	6.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—RORA—autistic disorder	3.56e-05	6.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GPX1—autistic disorder	3.54e-05	6.76e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.52e-05	6.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SERPINE1—autistic disorder	3.5e-05	6.68e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—COMT—autistic disorder	3.48e-05	6.65e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTP1—autistic disorder	3.47e-05	6.61e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MAOA—autistic disorder	3.46e-05	6.6e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAT—autistic disorder	3.37e-05	6.44e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK1—autistic disorder	3.35e-05	6.4e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MAOB—autistic disorder	3.34e-05	6.37e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP19A1—autistic disorder	3.28e-05	6.26e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—autistic disorder	3.27e-05	6.24e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTM1—autistic disorder	3.19e-05	6.08e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLA2G4A—autistic disorder	3.19e-05	6.08e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MAPK1—autistic disorder	3.14e-05	5.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TPH2—autistic disorder	3.1e-05	5.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MAPK1—autistic disorder	3.09e-05	5.9e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HRAS—autistic disorder	3.09e-05	5.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DPYD—autistic disorder	3.05e-05	5.83e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—COMT—autistic disorder	3.05e-05	5.82e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GPX1—autistic disorder	3.05e-05	5.82e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—autistic disorder	3.04e-05	5.81e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTP1—autistic disorder	3.04e-05	5.8e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MAOA—autistic disorder	3.03e-05	5.78e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—autistic disorder	2.96e-05	5.65e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAT—autistic disorder	2.96e-05	5.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—autistic disorder	2.89e-05	5.5e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNA1C—autistic disorder	2.84e-05	5.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—autistic disorder	2.83e-05	5.41e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—autistic disorder	2.82e-05	5.37e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTM1—autistic disorder	2.79e-05	5.33e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLA2G4A—autistic disorder	2.79e-05	5.33e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CG—autistic disorder	2.75e-05	5.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HRAS—autistic disorder	2.69e-05	5.13e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GPX1—autistic disorder	2.67e-05	5.1e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTEN—autistic disorder	2.67e-05	5.09e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—autistic disorder	2.62e-05	5e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—autistic disorder	2.61e-05	4.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DHFR—autistic disorder	2.58e-05	4.93e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—autistic disorder	2.58e-05	4.91e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HRAS—autistic disorder	2.52e-05	4.81e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTEN—autistic disorder	2.52e-05	4.8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HRAS—autistic disorder	2.48e-05	4.74e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—autistic disorder	2.47e-05	4.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—autistic disorder	2.38e-05	4.54e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CG—autistic disorder	2.37e-05	4.51e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—autistic disorder	2.3e-05	4.38e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—autistic disorder	2.25e-05	4.3e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK1—autistic disorder	2.17e-05	4.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—autistic disorder	2.09e-05	3.98e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CG—autistic disorder	2.07e-05	3.95e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP19A1—autistic disorder	2.02e-05	3.86e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—autistic disorder	1.97e-05	3.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—COMT—autistic disorder	1.88e-05	3.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTP1—autistic disorder	1.87e-05	3.57e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MAOA—autistic disorder	1.87e-05	3.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAT—autistic disorder	1.82e-05	3.47e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTEN—autistic disorder	1.82e-05	3.47e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—autistic disorder	1.8e-05	3.43e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HRAS—autistic disorder	1.74e-05	3.32e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLA2G4A—autistic disorder	1.72e-05	3.28e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM1—autistic disorder	1.72e-05	3.28e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—autistic disorder	1.67e-05	3.18e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX1—autistic disorder	1.65e-05	3.14e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—autistic disorder	1.57e-05	3e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTEN—autistic disorder	1.57e-05	2.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—autistic disorder	1.52e-05	2.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—autistic disorder	1.42e-05	2.7e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTEN—autistic disorder	1.37e-05	2.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.28e-05	2.44e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—autistic disorder	1.22e-05	2.32e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—autistic disorder	9.7e-06	1.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTEN—autistic disorder	8.46e-06	1.61e-05	CbGpPWpGaD
